References
Burmeister H, Aebi S, Studer C et al (2012) Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting. Support Care Cancer 20(1):141–147
Tendas A, Sollazzo F, Niscola P et al (2012) Management of chemotherapy-induced nausea and vomiting in adult patients after haematopoietic stem cell transplantation: adherence to guidelines and costs analysis from the Quality of Life Working Party of the Rome Transplant Network (EBMT 2012 Abstract N1228). Bone Marrow Transplant 47:S459–S470. doi:10.1038/bmt.2012.39
Tendas A, Sollazzo F, Bruno A et al (2012) Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant. Support Care Cancer 20(5):891–892
Aapro M, Molassiotis A, Dicato M et al (2012) The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). Ann Oncol 23:1986–1992
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Tendas, A., Sollazzo, F., Niscola, P. et al. Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score. Support Care Cancer 21, 5–6 (2013). https://doi.org/10.1007/s00520-012-1550-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-012-1550-4